Comparison of Combination Therapy of Olmesartan plus Azelnidipine or Hydrochlorothiazide on Renal and Vascular Damage in SHR/NDmcr-cp Rats

Publisher： Karger

E-ISSN： 1423-0143|34|2|87-96

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.34, Iss.2, 2011-01, pp. : 87-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial Effects of Combination Therapy with Olmesartan and Azelnidipine in Murine Polycystic Kidneys

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-09 ,pp. : 239-249

Karger

Access to resources Recommend Favorite

Tubular Cell Apoptosis and Proliferation in the Early Phase of Renal Damage in Uninephrectomized SHR

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 1, 2002-02 ,pp. : 13-19

Karger

Access to resources Recommend Favorite

Adverse Renal Effects of the AGE Inhibitor Pyridoxamine in Combination with ACEi in Non-Diabetic Adriamycin-Induced Renal Damage in Rats

By  

Kidney and Blood Pressure Research, Vol. 31, Iss. 5, 2008-11 ,pp. : 350-359

Karger

Access to resources Recommend Favorite

Combination Therapy with Benazepril and Oral Adsorbent Ameliorates Progressive Renal Fibrosis in Uremic Rats

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 297-312

Karger

Access to resources Recommend Favorite

Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan

By  

Cardiorenal Medicine, Vol. 3, Iss. 4, 2013-10 ,pp. : 221-231

Karger

Access to resources Recommend Favorite